KalVista Pharmaceuticals, Inc. (KALV)
26.72
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
26.75
+0.03
(+0.11%)
Pre-Market: 08:04
KalVista Pharmaceuticals Total Assets (Quarterly) : 335.38M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 842.13M |
| Recursion Pharmaceuticals, Inc. | 1.340B |
| Tango Therapeutics, Inc. | 410.01M |
| BioCryst Pharmaceuticals, Inc. | 465.05M |
| Iovance Biotherapeutics, Inc. | 913.17M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 338.09M |
| Shareholders Equity (Quarterly) | -2.711M |
| Debt to Equity Ratio | -104.83 |
| Current Ratio | 5.582 |
| Net Debt Paydown Yield | -6.76% |